Skip to main navigation Investor Relations Dynavax Overview Dynavax is a fully-integrated biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation to develop cutting-edge vaccines. The Company’s first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], a hepatitis B vaccine for adults, is approved in the United States. Upcoming Events NOV 30, 2021 AT 2:40 PM EST 4th Annual Evercore Virtual ISI HealthCONx Conference VIEW ALL EVENTS AND PRESENTATIONS Press Releases NOV 18, 2021 Dynavax to Present at the 4th Annual Evercore Virtual ISI HealthCONx Conference NOV 04, 2021 Dynavax Reports Third Quarter 2021 Financial Results NOV 02, 2021 Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OCT 21, 2021 Scott Myers Appointed to Dynavax Board of Directors and Elected Board Chairman VIEW ALL NEWS Email Alerts RSS Print Share Search © 2021 Dynavax Technologies. All rights reserved. Website Design: Hane Chow, Inc.

Skip to main navigation Committee Composition AUDIT NOMINATING AND CORPORATE GOVERNANCE COMPENSATION Scott D. Myers, MBA Francis R. Cano, Ph.D. Nominating and Corporate Governance Julie Eastland Audit Andrew Hack, M.D., Ph.D Audit Daniel L. Kisner, M.D. Nominating and Corporate Governance Compensation Brent MacGregor Nominating and Corporate Governance Peggy V. Phillips Audit Compensation Natale Ricciardi Compensation = Chairperson = Member = Chairman of the Board Email Alerts RSS Print Share Search ABOUT PRODUCT SCIENCE PORTFOLIO ONGOING STUDIES SEC Filings Annuals and Proxies Contact Us CAREERS CONTACT © 2021 Dynavax Technologies. All rights reserved. Website Design: Hane Chow, Inc.

Skip to main navigation Events & Presentations Corporate Presentation DATE DOCUMENTS Nov 04, 2021 Dynavax Technologies Corporate Presentation Upcoming Events DATE EVENT DETAILS Nov 30, 2021 at 2:40 PM EST 4th Annual Evercore Virtual ISI HealthCONx Conference Click here for webcast Add to Outlook Add to Google Calendar Archived Events DATE EVENT DETAILS Nov 4, 2021 at 4:30 PM EDT Dynavax Technologies Third Quarter 2021 Financial Results Listen to webcast Oct 13, 2021 at 12:00 PM EDT H.C. Wainwright 2nd Hepatitis B Virus (HBV) Virtual Conference Click here for webcast Oct 5, 2021 at 12:00 PM EDT Guggenheim 2nd Annual Vaccine and Infectious Disease Conference Click here for webcast Sep 30, 2021 at 12:00 PM EDT 2021 Cantor Virtual Global Healthcare Conference Click here for webcast View Presentation Sep 13, 2021 at 12:30 PM EDT H.C. Wainwright 23rd Annual Global Investment Conference Click here for webcast Aug 4, 2021 at 4:30 PM EDT Dynavax Technologies Second Quarter 2021 Financial Results Listen to webcast Email Alerts RSS Print Share Search ABOUT PRODUCT SCIENCE PORTFOLIO ONGOING STUDIES CAREERS CONTACT © 2021 Dynavax Technologies. All rights reserved. Website Design: Hane Chow, Inc.